Leipold, G.; Tóth, R.; Hársfalvi, P.; Lőczi, L.; Török, M.; Keszthelyi, A.; Ács, N.; Lintner, B.; Várbíró, S.; Keszthelyi, M.
Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial. Life 2024, 14, 835.
https://doi.org/10.3390/life14070835
AMA Style
Leipold G, Tóth R, Hársfalvi P, Lőczi L, Török M, Keszthelyi A, Ács N, Lintner B, Várbíró S, Keszthelyi M.
Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial. Life. 2024; 14(7):835.
https://doi.org/10.3390/life14070835
Chicago/Turabian Style
Leipold, Gergő, Richárd Tóth, Péter Hársfalvi, Lotti Lőczi, Marianna Török, Attila Keszthelyi, Nándor Ács, Balázs Lintner, Szabolcs Várbíró, and Márton Keszthelyi.
2024. "Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial" Life 14, no. 7: 835.
https://doi.org/10.3390/life14070835
APA Style
Leipold, G., Tóth, R., Hársfalvi, P., Lőczi, L., Török, M., Keszthelyi, A., Ács, N., Lintner, B., Várbíró, S., & Keszthelyi, M.
(2024). Comprehensive Evaluation of a Levonorgestrel Intrauterine Device (LNG-IUD), Metformin, and Liraglutide for Fertility Preservation in Endometrial Cancer: Protocol for a Randomized Clinical Trial. Life, 14(7), 835.
https://doi.org/10.3390/life14070835
